| Literature DB >> 36212594 |
Bradley Alexander1, Jared B Watson1, Kelly Chandler1, Mackenzie Sowers1, Gerald McGwin2, Nicola Maffulli3,4,5, Roshan Jacob1, Sameer Naranje1.
Abstract
Objectives: The number of revision total knee arthroplasty (TKA) procedures continues to rise, a direct consequence of the increase in primary TKA. The number of arthroplasty-trained orthopaedic surgeons has failed to increase at a corresponding rate, and the increased burden will ultimately fall on non-specialized orthopaedists. Resident involvement in primary TKA has not been found to increase postoperative complications, but revision TKA is more complex and the impact of resident involvement has not been well studied.Entities:
Keywords: NSQIP; Postoperative outcomes; Resident training; Revision total knee arthroplasty; Total knee arthroplasty
Year: 2022 PMID: 36212594 PMCID: PMC9519629 DOI: 10.1016/j.jtumed.2022.05.004
Source DB: PubMed Journal: J Taibah Univ Med Sci ISSN: 1658-3612
Medical comorbidities and preoperative demographics.
| Medical comorbidities and preoperative demographics (expressed as percentages) | Resident present (863) | Resident not present (971) | P-value |
|---|---|---|---|
| Gender | |||
| Male | 43.90 | 38.76 | 0.0286 |
| Female | 56.10 | 61.24 | |
| ASA classification | |||
| ASA 1 | 1.51 | 1.03 | 0.118 |
| ASA 2 | 43.92 | 40.10 | |
| ASA 3 | 50.52 | 55.67 | |
| ASA 4 | 3.94 | 2.99 | |
| ASA 5 | 0.12 | 0.00 | |
| Race | |||
| American Indian or Alaska Native | 0.54 | 1.12 | 0.120 |
| Asian | 0.27 | 0.56 | |
| Black or African American | 12.25 | 9.38 | |
| Native Hawaiian or Pacific Islander | 0.00 | 0.22 | |
| White | 86.94 | 88.73 | |
| Anesthesia | |||
| Epidural | 2.78 | 2.78 | <0.001 |
| General | 59.44 | 59.90 | |
| MAC/IV sedation | 0.46 | 0.21 | |
| Monitored anesthesia care | 0.12 | 0.21 | |
| Regional | 10.20 | 2.37 | |
| Spinal | 26.42 | 34.43 | |
| None | 0.35 | 0.00 | |
| Other | 0.23 | 0.10 | |
| COPD | 3.71 | 3.81 | 1 |
| Congestive heart failure in 30 days before surgery | 0.35 | 0.31 | 1 |
| History of myocardial infarction 6 months prior to surgery | 0.12 | 0.21 | 1 |
| History of angina in 1 month before surgery | 0.70 | 0.85 | 0.792 |
| Acute renal failure (post-op) | 0.23 | 0.31 | 1 |
| Previous percutaneous coronary intervention (PCI) | 9.40 | 9.59 | 0.936 |
| EtOH >2 drinks/day in 2 weeks before admission | 2.32 | 2.77 | 0.654 |
| Previous cardiac surgery | 5.22 | 5.33 | 1 |
| History of revascularization/amputation for peripheral vascular disease | 0.70 | 0.85 | 0.792 |
| Currently on dialysis (pre-op) | 0.35 | 0.62 | 0.514 |
| History of transient ischemic attacks (TIA) | 3.48 | 3.94 | 0.621 |
| CVA/Stroke with neurological deficit | 0.70 | 1.28 | 0.243 |
| Paraplegia | 0.46 | 0.43 | 1 |
| Hemiplegia | 0.00 | 0.11 | 1 |
| Quadriplegia | 0.12 | 0.00 | 0.479 |
| Chemotherapy for malignancy in ≤30 days pre-op | 0.35 | 0.21 | 0.675 |
| Disseminated cancer | 0.23 | 0.21 | 1 |
| Steroid use for chronic condition | 4.17 | 3.09 | 0.258 |
| Weight loss (>10% loss body weight in last 6 months) | 0.58 | 0.93 | 0.434 |
| Bleeding disorders | 5.10 | 4.94 | 0.915 |
| Prior operation within 30 days | 2.67 | 3.28 | 0.491 |
| Hypertension requiring medication | 64.08 | 70.75 | 0.0027 |
| Current smoker within one year | 11.12 | 11.64 | 0.769 |
| Diabetes status | |||
| Diabetes mellitus managed with insulin | 6.84 | 6.18 | 0.0012 |
| Diabetes mellitus managed without oral agents or insulin | 81.58 | 78.58 | |
| Diabetes mellitus managed with non-oral and non-insulin agents | 8.23 | 7.62 | |
| Diabetes mellitus managed with oral agents | 3.36 | 7.62 | |
| Functional health status prior to surgery | |||
| Independent | 94.29 | 94.42 | 0.945 |
| Partially dependent | 5.71 | 5.58 | |
| Inpatient | 98.84 | 99.28 | 0.342 |
Total operative time, length of stay, and postoperative complications.
| Operative time, length of stay, and postoperative complications | Resident present (863) | Resident not present (971) | P-value |
|---|---|---|---|
| Operative time (min) | 147.50 | 124.55 | <0.001 |
| Length of stay (days) | 4.77 | 4.01 | <0.001 |
| Graft/Prosthesis/Flap failure | 0.00% | 0.10% | 1 |
| Superficial infection | 0.93% | 0.41% | 0.246 |
| Deep infection | 0.46% | 0.93% | 0.276 |
| Wound dehiscence | 0.81% | 0.72% | 1 |
| Reoperation | 3.01% | 4.02% | 0.258 |
| Pneumonia | 0.58% | 0.62% | 1 |
| Unplanned intubation | 0.35% | 0.41% | 1 |
| Deep vein thrombosis | 1.16% | 0.62% | 0.315 |
| Pulmonary embolism | 0.12% | 0.62% | 0.129 |
| Ventilation >48 h | 0.23% | 0.41% | 0.690 |
| Renal insufficiency | 0.35% | 0.31% | 1 |
| Acute renal failure | 0.12% | 0.31% | 0.627 |
| Urinary tract infection | 1.74% | 1.75% | 1 |
| Stroke/CVA | 0.00% | 0.10% | 1 |
| Peripheral nerve injury | 0.12% | 0.31% | 0.627 |
| Cardiac arrest | 0.00% | 0.21% | 0.502 |
| Myocardial infarction | 0.23% | 0.51% | 0.458 |
Multivariable regression analysis with total operative time as the dependent variable.
| Covariates | Change in operative time, min | P-value |
|---|---|---|
| Gender – Female | −12.95 | <0.001 |
| ASA Classification 1 | −38.87 | 0.016 |
| ASA Classification 2 | −7.74 | 0.036 |
| Race – Black or African American | 13.77 | 0.010 |
| Anesthesia – Regional | −10.61 | <0.001 |
| Anesthesia – Spinal | −12.02 | 0.001 |
| Prior operation within 30 days – Yes | −25.40 | 0.006 |
| Outpatient | −51.91 | 0.002 |
| Resident present | 25.92 | <0.001 |
Multivariable regression analysis with length of hospital stay as the dependent variable.
| Covariates | Change in length of hospital stay, days | P-value |
|---|---|---|
| Age | 0.029 | <0.001 |
| ASA classification 2 | −0.81 | <0.001 |
| ASA classification 4 | 1.88 | <0.001 |
| Race – Black or African American | 1.34 | <0.001 |
| Race – Native Hawaiian or Pacific Islander | 5.31 | 0.032 |
| Cerebrovascular accident | 1.94 | 0.034 |
| Steroid use for a chronic condition | 1.11 | 0.024 |
| Prior operation within 30 days – Yes | 6.95 | <0.001 |
| Outpatient | −2.70 | 0.003 |
| Resident present | 0.34 | 0.061 |